Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
ConnectRN is a tech-enabled network built to improve clinicians' lives through access to community, opportunity, and support.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
SiMa.ai is a developer of machine learning technology to deliver a software-centric platform.
Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.
Climb Bio occurs when the immune system mistakenly attacks the body's tissues and can result in permanent organ damage or even death.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Spyre Therapeutics is a biotechnology business that is developing a strong pipeline of antibody therapies.
Menlo Micro is the developer of the Ideal Switch, an electromechanical switch technology used to switch AC/DC and RF.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
Adage Capital Management has invested in 76 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Adage Capital Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Pharmaceutical, Biopharma. The firm invests across 27 different industry categories.
Among tracked funding rounds, Spyre Therapeutics received $403.0M in a Post-IPO Equity round. Adage Capital Management's total known invested capital is $11.1B.
Adage Capital Management's average investment size is $160.5M across its portfolio of 76 companies.
Recent Adage Capital Management portfolio additions include Monopar, Ventyx Biosciences, Arvinas, CinCor Pharma, LB Pharmaceuticals. These companies were founded in 2020 or later.